Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health Corp    CVS

Delayed Quote. Delayed  - 09/26 05:25:35 pm
89.525 USD   -1.19%
09/25 PHARMACY SHUTDO : Independent businesses being swallowed up by falli..
09/22 DAILY DIVIDEND : Lmt, idcc, safm, cvs, len
09/22 CVS HEALTH CORP : Announces Quarterly Dividend
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Court Rules Two CVS Florida Pharmacies Can't Ship Pain Pills

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/22/2012 | 11:59pm CEST
   By John Kell 
   Of  
 

A U.S. appeals court said two CVS Caremark Corp. (>> CVS Caremark Corporation) pharmacies in Florida cannot fill prescriptions for certain controlled drugs related to a Drug Enforcement Administration move to halt such sales.

The decision lifted a temporary, administrative stay that was granted to CVS earlier this month, at the time allowing the pharmacies to keep dispensing controlled medications after an appeals court denied the chain's request for preliminary injunction.

The case stems from DEA action that was taken last month against two Sanford, Fla., CVS stores that were alleged to be among four pharmacy customers of drug distributor Cardinal Health Inc. (CAH) that dispensed the pain drug oxycodone based on bad prescriptions.

The U.S. Court of Appeals for the District of Columbia Circuit on Thursday ruled CVS had "not satisfied the stringent requirements for a stay pending appeal." The decision comes roughly a week after an appeals court said a Cardinal Health distribution hub in Florida can't ship prescription painkillers.

In a prepared statement, CVS said it was "disappointed with today's ruling by the court," saying the company had taken actions that have substantially reduced the amount of oxycodone dispensed at the two Florida pharmacies.

"We remain committed to working with the DEA to do everything we can to reduce prescription drug abuse," CVS said.

-By John Kell, Dow Jones Newswires; 212-416-2480; john.kell@dowjones.com

-Jon Kamp and Timothy Martin of The Wall Street Journal contributed to this article

Stocks mentioned in the article : CVS Caremark Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORP
09/25 PHARMACY SHUTDOWNS : Independent businesses being swallowed up by falling reimbu..
09/22 DAILY DIVIDEND REPORT : Lmt, idcc, safm, cvs, len
09/22 CVS HEALTH CORPORATION : Announces Quarterly Dividend
09/22 CVS HEALTH : The First Tobacco-Free Generation Is Within Reach
09/22 CVS HEALTH : to offer curbside pickup in Chicago area
09/19 CVS HEALTH : Expands Youth Drug Abuse Prevention Efforts for the 2016-2017 Schoo..
09/15 CVS HEALTH : Increasing Access to Health Care with Annual Project Health Campaig..
09/15 CVS HEALTH : 's ScriptSync® Service Marks One Year Anniversary
09/15 CVS HEALTH : EDITORIAL CVS settlement is positive step in addiction fight
09/14 CVS HEALTH : Bringing Health Screenings to Underserved Communities
More news
Sector news : Drug Retailers - NEC
09/23DJRITE AID : Business Watch -- WSJ
09/22DJRITE AID : Same-Store Sales Fall Amid Generics Pressure
09/15 MCKESSON : German antitrust watchdog raids drugs distributors
09/14DJGoogle Acquisition Apigee's Revenue Climbs
09/14DJGoogle Acquisition Apigee's Revenue Climbs
More sector news : Drug Retailers - NEC
News from SeekingAlpha
09/25 PORTFOLIO PURCHASES : Adding 3 Companies With More Than 15% Upside To Our Divide..
09/23 Examining The Core Value Of REITs
09/22 Where Did All That EpiPen Money Go?
09/22 CVS Health declares $0.425 dividend
09/22 Amazon Threatens The Photo Printing Services Of Shutterfly, CVS, Walgreens, W..
Advertisement
Financials ($)
Sales 2016 179 864 M
EBIT 2016 10 786 M
Net income 2016 5 715 M
Debt 2016 24 998 M
Yield 2016 1,80%
P/E ratio 2016 17,50
P/E ratio 2017 14,55
EV / Sales 2016 0,68x
EV / Sales 2017 0,62x
Capitalization 96 599 M
More Financials
Chart CVS HEALTH CORP
Duration : Period :
CVS Health Corp Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Full-screen chart
Technical analysis trends CVS HEALTH CORP
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 111 $
Spread / Average Target 23%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Non-Executive Chairman
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Stephen J. Gold Chief Information Officer & Executive Vice Preside
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH CORP-7.33%96 599
WALGREENS BOOTS ALLIAN..-3.65%88 804
EXPRESS SCRIPTS HOLDIN..-18.38%44 960
MCKESSON CORPORATION-15.29%37 710
CARDINAL HEALTH INC-13.01%24 848
AMERISOURCEBERGEN CORP..-19.65%19 823
More Results